bibliographic resource 435665 [br/435665]
https://w3id.org/oc/corpus/br/435665
- is a
-
- title
-
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-